Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis

NCT03832738 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis
Psoriasis
Skin Diseases

Interventions

DRUG: JTE-451 Tablets
DRUG: Placebo Tablets

Sponsor

Akros Pharma Inc.